Dr. Ewa M. Szczypinska, MD

Dr. Szczypinska practices at South Seminole Hospital in Longwood, Florida.

Dr. Szczypinska's NPI, 1821285958, was assigned on October 2, 2007. Dr. Szczypinska holds Florida license ME102289.

Dr. Szczypinska's primary practice is South Seminole Hospital, at 555 W Sr 434, Longwood, FL 32750 in Seminole County. The practice phone is (321) 841-3492.

Dr. Szczypinska's primary practice is South Seminole Hospital in Longwood, Florida. Dr. Szczypinska is also affiliated with Orlando Regional Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Szczypinska to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Szczypinska practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Szczypinska's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Szczypinska is licensed in Florida.

CMS data shows 45 Medicare services from Dr. Szczypinska across 2 procedure codes in 2024, for 51 Medicare patients. Medicare paid $3,645 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 51 Medicare patients who saw Dr. Szczypinska in 2024. The largest group is 75 to 84, with 18 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Szczypinska's median patient age at 77, with 52% women.

In 2024, Dr. Szczypinska wrote 32 Medicare Part D claims for 15 patients. 88% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $82 in total drug cost. In 2021, CMS named 48 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Szczypinska for performance year 2024, reported as part of a group. Dr. Szczypinska accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 8 general payments to Dr. Szczypinska from 4 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 71% of the total. Theratechnologies Inc. paid the most, $147.